To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Epoetin beta
Epoetin beta (rINN) (pronounced /ɛˈpoʊɨtɨn/) is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Additional recommended knowledgeEpoetin is marketed under the trade names NeoRecormon.[2] It is only sold in Europe. References
Categories: Drugs | Growth factors | Erythropoiesis-stimulating agents |
||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Epoetin_beta". A list of authors is available in Wikipedia. |
- Diaxonhit Enters into Exclusive Partnership Agreement with Japanese Tosoh Group for Marketing Immunoassay Instruments
- Immune memory formation seen in early stages of viral infection
- Edible, fluorescent silk tags can suss out fake medications - The codes within the tags can be read by a smartphone app
- GeneEd Appoints Mr. Takashi Nakamura to Its Business Advisory Board - Renowned Executive to Contribute to the Development of GeneEd's Life Science e-Learning Business in Far East
- Jeschajahu_Leibowitz